The Valley Desk

NCT00520975 · Interventional trial

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

Overall registry status Terminated

Phase 3

Conditions Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov